Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication May 4, 2023
- Revision received September 16, 2023
- Published online January 2, 2024.
Article Versions
- previous version (October 19, 2023 - 09:02).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2024 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Lisa Steinhelfer*,1,2,
- Lukas Lunger*,3,
- Lisena Cala1,
- Christian H. Pfob4,
- Constantin Lapa4,
- Philipp E. Hartrampf5,
- Andreas K. Buck5,
- Hannah Schäfer6,
- Christoph Schmaderer6,
- Robert Tauber3,
- Julia Brosch-Lenz1,
- Bernhard Haller7,
- Valentin H. Meissner3,
- Karina Knorr1,
- Wolfgang A. Weber1 and
- Matthias Eiber1
- 1Department of Nuclear Medicine, School of Medicine, and Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany;
- 2Department of Radiology, School of Medicine, and Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany;
- 3Department of Urology, School of Medicine, and Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany;
- 4Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany;
- 5Department of Nuclear Medicine, University Hospital Wurzburg, Wurzburg, Germany;
- 6Department of Nephrology, School of Medicine, and Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany; and
- 7Institute of AI and Informatics in Medicine, School of Medicine, and Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
- For correspondence or reprints, contact Lukas Lunger (lukas.lunger{at}tum.de).
Statistics from Altmetric.com
Cited By...
Article usage
In this issue
Jump to section
Related Articles
Cited By...
- Rethinking Dosimetry: A European Perspective
- Mathematic Modeling of Tumor Growth During [177Lu]Lu-PSMA Therapy: Insights into Treatment Optimization
- Challenges with 177Lu-PSMA-617 Radiopharmaceutical Therapy in Clinical Practice
- Initial Experience with [177Lu]Lu-PSMA-617 After Regulatory Approval for Metastatic Castration-Resistant Prostate Cancer: Efficacy, Safety, and Outcome Prediction
- Safety and Efficacy of Extended Therapy with [177Lu]Lu-PSMA: A German Multicenter Study
- Unraveling the Impact of 177Lu-PSMA Radioligand Therapy on Renal Impairment: Distinguishing Causation from Correlation